Comparison of combined ketamine and tramadol with solely ketamine and Tramadol on reduction of post-operative pain of pyelolithotomy operation

Comparison of the effects of wound infiltration of combined ketamine and tramadol with solely ketamine and Tramadol on reduction of post-operative pain of pyelolithotomy operation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201501243773N12

Enrollment

Registered

2015-01-31

Start date

2013-03-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post operative pain at pelvic region. Pelvic and perineal pain

Interventions

Intervention 1: Control group will be received no drug as prevention of post operative pain. Intervention 2: First intervention group: tramadol 0.5% 1 mL. Intervention 3: Second intervention group: tr

Prevention

Control group will be received no drug as prevention of post operative pain

First intervention group: tramadol 0.5% 1 mL

Second intervention group: tramadol 0.5% 1 mL + ketamine 0.5mg/kg

Third intervention group: ketamine 0.5mg/kg

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients scheduled pyelolithotomy; ASA1-2. exclusion criteria: Opium addiction; Psychologic disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Post operative pain. Timepoint: At 5/10/15/30 minutes after the exit recovery and 1/3/6/12/24 hours after entrance to the ward. Method of measurement: visual analogue score.	—

Secondary

Measure	Time frame
Agitation / sedation level. Timepoint: 5/10/15/30 minutes after the exit recovery. Method of measurement: Richmond Agitation-Sedation Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarziyeh Navardi Masule

Tehran University of Medical Sciences \ Medicine Faculty

navardi@yahoo.com+98 21 63120

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026